Order Article Reprints

Wang X, Zhou Y, Wang Y, Wang X, Zhang Y, Mao Y, Zhang L, Qi J, Zhang Y, Lyu F, et al. SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide. Journal of Clinical Medicine. 2022; 11(16):4765. https://doi.org/10.3390/jcm11164765

Wang, Xu, Yi Zhou, Yan Wang, Xiang Wang, Yu Zhang, Yufei Mao, Long Zhang, Ji Qi, Yining Zhang, Feng Lyu, and et al. 2022. "SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide" Journal of Clinical Medicine 11, no. 16: 4765. https://doi.org/10.3390/jcm11164765

Wang, X., Zhou, Y., Wang, Y., Wang, X., Zhang, Y., Mao, Y., Zhang, L., Qi, J., Zhang, Y., Lyu, F., Gu, L., Yu, R., & Zhou, X. (2022). SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide. Journal of Clinical Medicine, 11(16), 4765. https://doi.org/10.3390/jcm11164765